MarketWatch
Merck makes a big move into new cancer treatments with a $6.7 billion buyout deal
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is developing an oral treatment for leukemia.
M
Source
MarketWatch
Read full article at MarketWatch
Opens original article in a new tab
Advertisement